Los Angeles Capital Management
TBIO

Los Angeles Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Los Angeles Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-27,469
Closed -$756K – 1637
2021
Q2 		$756K Sell
27,469
-1,360
-5% -$26.7K ﹤0.01% 981
2021
Q1 		$475K Sell
28,829
-18,651
-39% -$425K ﹤0.01% 1237
2020
Q4 		$875K Buy
47,480
+1,500
+3% +$26.8K ﹤0.01% 995
2020
Q3 		$626K Buy
45,980
+32,460
+240% +$500K ﹤0.01% 998
2020
Q2 		$242K Buy
+13,520
New +$204K ﹤0.01% 1348

Los Angeles Capital Management's TBIO Position: Q3 2021 in Review

Los Angeles Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 27,469 shares — an estimated $756K sold.

Los Angeles Capital Management first reported a position in TBIO in Q2 2020 and held it in 5 quarters. The position peaked at $875K in Q4 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Los Angeles Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Los Angeles Capital Management sold 27,469 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $756K.
  • Los Angeles Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Los Angeles Capital Management's Translate Bio, Inc. Common Stock position peaked at $875K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Los Angeles Capital Management's 13F filing for Q3 2021, filed 5 Nov 2021.